Strattera provides an irritating action on the sympathetic nervous system, and so the metabolic processes are improved in the brain and the level of neurotransmitters is increased.
The main active ingredient of Atomoxetine increases a concentration of noradrenaline. This hormone is responsible for awakening and active brain work. It provides a stimulating action on the central nervous system and inhibits the symptoms of such disorders as:
- Attention deficit disorder
- Hyperactivity syndrome
- Prolonged depression resistant to the treatment
- Reduction of the cognitive functions of the brain
Strattera increases an attentiveness and reduces anxiety. Children taking the drug become more patient, easily communicate with peers, learn new information easily and show high results in the education.
Unlike psychostimulants used for the treatment of the attention deficit disorder, Strattera does not cause a medical addiction. It means that a child or an adult will not have a depression and will not feel helplessness. An effect of euphoria does not appear.
According to the results of the medical studies, a level of the pharmacological safety of Strattera is even higher than Ritalin, although all pharmacological functions of these drugs are the same.
In what dose is Strattera used?
Strattera is produced in tablets in doses of 10 mg, 18 mg, 25 mg, 40 mg. The tablets should be used orally with a glass of water. It is better to take a daily dose in the morning before or after breakfast. But in case of the side effects, a dose may be divided, and one half is taken in the morning, and another half is taken in the afternoon or early evening.
Children and teenagers with the body weight up to 70 kg:
- A recommended initial daily dose is 0,5 mg per 1 kg of the body weight that is increased up to 1,2 mg per 1 kg of the body weight in 5 days
- If a therapeutic effect is absent, a dose may be temporarily increased up to 1,8 mg per 1 kg of the body weight but not earlier than in 4 weeks after beginning of the treatment
Children and teenagers with the body weight more than 70 kg and adults:
- A recommended starting daily dose is 40 mg of Strattera
- A dose is increased up to 80 mg per day in 3-5 days
- If a state is not improved, the daily dose of Strattera may be increased up to the maximal one – 120 mg but only in 4 weeks
Patients with dysfunctions of kidneys reduce the starting and maintaining dose by two times.
- Strattera is not used within 2 weeks after a cessation of MAO inhibitors
- Drugs affecting the concentration of noradrenaline may increase/reduce Strattera effect
- Strattera is not recommended during closed-angle glaucoma, tachycardia, disorder of the cerebral circulation, pregnancy
- Children under 6 years old do not take Strattera
Children and teenagers taking Strattera often have the following side effects: dizziness, low appetite, early morning awakening, abdominal pain, dermatitis.
The side effects may be controlled by means of the dose adjustment. If you noticed that your child suffers from negative symptoms, it is necessary to lower the daily dose.